LABORIE Acquires Andromeda

Thursday, March 09, 2017

Laborie Medical Technologies ("LABORIE"), a leading developer and manufacturer of medical devices in the pelvic health and gastroenterology market, has completed its acquisition of ANDROMEDA Medizinische Systems GmbH ("Andromeda").  Headquartered in Potzham, Germany, Andromeda is a European market leader in Urodynamics.

LABORIE's acquisition of Andromeda extends its Urodynamic product offering in Europe, specifically Germany. Additionally, Andromeda's product lines complement LABORIE's Urodynamic product offering and further extend its global reach.

"This is another important acquisition for LABORIE as we build out a strong global platform," stated Brian Ellacott, LABORIE President and CEO. "Andromeda has built a very loyal customer base in Europe and we look forward to working with the Andromeda team to provide more products and services to their customers."